venture capital

Biotech Allison DeAngelis

Once a small player among biotech VCs, Mubadala Capital Ventures is punching above its weight

The Readout LOUD Damian Garde and Allison DeAngelis

Fauci’s non-retirement, grading biotech VCs, & a bellwether IPO

Biotech Kate Sheridan

OrbiMed tumbles from the top of STAT’s biotech venture capital performance ranking

Biotech Kate Sheridan

Private equity giant Carlyle to acquire biotech venture capital firm Abingworth

Business Meghana Keshavan

There’s just one female CEO among San Diego’s public biotechs. Here’s why

First Opinion Steve Brozak

Theranos debacle may scare investors away from diagnostic technology

Business Rebecca Robbins

Balding heads. Buzzwords. Biotech execs refine the art of the pitch

Business Andrew Joseph

Companies seek to diagnose cancer from a blood sample